EXPE vs FBIOP · P/E 20, rev $7.74B vs $44.3M cap
Expedia Group Inc. (EXPE) versus Fortress Biotech Inc Pref Series A (FBIOP) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Fortress Biotech Inc Pref Series A (FBIOP) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
FBIOP does not have a complete income-statement cache yet.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. FBIOP currently screens at market cap $44.3M.
Not investment advice. Open the EXPE and FBIOP stock pages for the full models.
Not investment advice.